30/07/2024 - Ocular Therapeutix Inc.: Ocular Therapeutix™ Announces First Patients Enrolled in Phase 3 SOL-R Wet AMD Study

The text version of this document is not available. You can access the original document here.

Attachments

• Original Link
• Permalink

Disclaimer

Ocular Therapeutix Inc. published this content on 30 July 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 July 2024 11:51:29 UTC.